» Articles » PMID: 15624092

[Cystic Pancreas Tumors and Their Classification: Features Old and New]

Overview
Journal Pathologe
Specialty Pathology
Date 2004 Dec 30
PMID 15624092
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Cystic tumors and tumor-like lesions of the pancreas are rare, but have attracted a great deal of attention because they are easily recognized with new imaging methods and, in contrast to ductal adenocarcinoma, they can usually be cured surgically. The increasing resection rate in recent years has also increased our knowledge of cystic pancreatic tumors by conspicuously enlarging their morphological spectrum. Known entities have been better characterized (i.e. solid pseudopapillary neoplasm, intraductal papillary mucinous neoplasm) and new ones described (serous oligocystic adenoma, mucinous non-neoplastic cyst, acinar cell cystadenoma and cystic hamartoma). This review discusses the most important cystic tumors and tumor-like lesions, presents a new classification, and summarizes the immunohistochemical differential diagnosis.

Citing Articles

Diagnostic, Structured Classification and Therapeutic Approach in Cystic Pancreatic Lesions: Systematic Findings with Regard to the European Guidelines.

Kloth C, Haggenmuller B, Beck A, Wagner M, Kornmann M, Steinacker J Diagnostics (Basel). 2023; 13(3).

PMID: 36766560 PMC: 9914853. DOI: 10.3390/diagnostics13030454.


[A rare cause of left-sided epigastric pain].

von Frankenberg J, Schildberg C, Schreyer A, Hippe S, Paasch C, Mantke R Chirurgie (Heidelb). 2022; 93(9):902-904.

PMID: 35925140 DOI: 10.1007/s00104-022-01649-0.


Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Review of Their Genetic Characteristics and Mouse Models.

Li J, Wei T, Zhang J, Liang T Cancers (Basel). 2021; 13(21).

PMID: 34771461 PMC: 8582516. DOI: 10.3390/cancers13215296.


Pancreatic ductal adenocarcinomas associated with intraductal papillary mucinous neoplasms (IPMNs) versus pseudo-IPMNs: relative frequency, clinicopathologic characteristics and differential diagnosis.

Muraki T, Jang K, Reid M, Pehlivanoglu B, Memis B, Basturk O Mod Pathol. 2021; 35(1):96-105.

PMID: 34518632 DOI: 10.1038/s41379-021-00902-x.


The Clinical and Socio-Economic Relevance of Increased IPMN Detection Rates and Management Choices.

Budde C, Beyer G, Kuhn J, Lerch M, Mayerle J Viszeralmedizin. 2015; 31(1):47-52.

PMID: 26286668 PMC: 4433134. DOI: 10.1159/000375455.


References
1.
Albores-Saavedra J . Acinar cystadenoma of the pancreas: a previously undescribed tumor. Ann Diagn Pathol. 2002; 6(2):113-5. DOI: 10.1053/adpa.2002.32379. View

2.
George D, Murphy F, Michalski R, Ulmer B . Serous cystadenocarcinoma of the pancreas: a new entity?. Am J Surg Pathol. 1989; 13(1):61-6. DOI: 10.1097/00000478-198901000-00009. View

3.
Wouters K, Ectors N, Van Steenbergen W, Aerts R, Driessen A, Van Hoe L . A pancreatic mucinous cystadenoma in a man with mesenchymal stroma, expressing oestrogen and progesterone receptors. Virchows Arch. 1998; 432(2):187-9. DOI: 10.1007/s004280050154. View

4.
Sessa F, Solcia E, Capella C, Bonato M, Scarpa A, Zamboni G . Intraductal papillary-mucinous tumours represent a distinct group of pancreatic neoplasms: an investigation of tumour cell differentiation and K-ras, p53 and c-erbB-2 abnormalities in 26 patients. Virchows Arch. 1994; 425(4):357-67. DOI: 10.1007/BF00189573. View

5.
Paal E, Thompson L, Heffess C . A clinicopathologic and immunohistochemical study of ten pancreatic lymphangiomas and a review of the literature. Cancer. 1998; 82(11):2150-8. DOI: 10.1002/(sici)1097-0142(19980601)82:11<2150::aid-cncr9>3.0.co;2-z. View